Introduction: Acupuncture has been used for pain management for thousands of years. However, it is largely unclear whether this therapeutic approach can effectively reduce heart failure-associated symptoms, including dyspnea. The hypothesis posited in this study was that acupuncture does indeed aid in the management of such symptoms and was motivated by the following statistics that establish a requisite need for efficient management of dyspnea to improve patient outcomes with heart failure. In 2020, an estimated 6.2 million adults in the USA had a heart failure diagnosis; in 2018, 379,800 death certificates reported heart failure; and the national cost of heart failure in 2012 was approximately USD 30.7 billion. Methods: The methodology employed to conduct this study involved review of trial data extracted from review of papers pertaining to acupuncture, symptoms of heart failure, and dyspnea, from academic and clinical data repositories subject to various inclusion and exclusion criteria. Of the initial set of 293 studies identified, the resulting inclusion set comprised 30 studies. The analysis conducted revealed that the highest frequency of combined acupuncture points prescribed for the foregoing search criteria were as follows: BL13, BL23, LU9, LU5, Dingchuan, LI4, PC6, and HT7. Results: A meta-analysis of combined pooled p values for the studies revealed that acupuncture does aid in the management of symptoms of dyspnea and heart failure, subject to various limitations including but not limited to heterogeneity inherent between the studies in the inclusion set that were analyzed. Such limitations underscore the need to restrict generalizations from the conclusions of this study. Conclusion: The impact and novelty of this research study is its attempt to target the apparent paucity of literature that focuses on the management of dyspnea specifically in the context of heart failure with acupuncture and to bridge the gap of the application of acupuncture research on dyspnea to the cardiovascular context of heart failure. Notwithstanding the meta-analysis undertaken under this review study, further statistical analysis and a pilot study are warranted to consolidate or nullify the results of the research.

1.
American Heart Association [Internet]
. Dallas: American Heart Association [Internet]. Dallas: what is heart failure? [cited 2023 April 2]. Available from: https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure.
2.
American Heart Association [Internet]
. Dallas: American Heart Association [Internet]. Dallas: Heart Failure Signs and Symptoms [cited 2023 April 2]. Available from: https://www.heart.org/en/health-topics/heart-failure/warning-signs-of-heart-failure
3.
Benjamin
EJ
,
Muntner
P
,
Alonso
A
,
Bittencourt
MS
,
Callaway
CW
,
Carson
AP
, et al
.
Heart disease and stroke statistics: 2019 update: a report from the American Heart Association
.
Circulation
.
2019
;
139
(
10
):
e56
528
.
4.
Virani
SS
,
Alonso
A
,
Benjamin
EJ
,
Bittencourt
MS
,
Callaway
CW
,
Carson
AP
, et al
.
Heart disease and stroke statistics: 2020 update: a report from the American Heart Association
.
Circulation
.
2020
;
141
(
9
):
e139
596
.
5.
Lee
H
,
Kim
TH
,
Leem
J
.
Acupuncture for heart failure: a systematic review of clinical studies
.
Int J Cardiol
.
2016
;
222
:
321
31
.
6.
Parshall
MB
,
Schwartzstein
RM
,
Adams
L
,
Banzett
RB
,
Manning
HL
,
Bourbeau
J
, et al
.
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea
.
Am J Respir Crit Care Med
.
2012
;
185
(
4
):
435
52
.
7.
Rapaport
E
.
Dyspnea: pathophysiology and differential diagnosis
.
Prog Cardiovasc Dis
.
1971
;
13
(
6
):
532
45
.
8.
Bozkurt
B
,
Mann
DL
.
Shortness of breath
.
Circulation
.
2003
;
108
(
2
):
e13
.
9.
Johnson
MJ
,
Oxberry
SG
.
The management of dyspnoea in chronic heart failure
.
Curr Opin Support Palliat Care
.
2010
;
4
(
2
):
63
8
.
10.
Von Trott
P
,
Oei
SL
,
Ramsenthaler
C
.
Acupuncture for breathlessness in advanced diseases: a systematic review and meta-analysis
.
J Pain Symptom Manage
.
2020
;
59
(
2
):
327
38.e3
.
11.
American Heart Association [Internet]
.
Dallas: causes and risks for heart failure
. [cited 2023 April 2]. Available from: https://www.heart.org/en/health-topics/heart-failure/causes-and-risks-for-heart-failure.
12.
Wu
HC
,
Lin
JG
,
Chu
CH
,
Chang
YH
,
Chang
CG
,
Hsieh
CL
, et al
.
The effects of acupuncture on cardiac muscle cells and blood pressure in spontaneous hypertensive rats
.
Acupunct Electrother Res
.
2004
;
29
(
1–2
):
83
95
.
13.
Uchida
S
,
Kagitani
F
,
Hotta
H
.
Mechanism of the reflex inhibition of heart rate elicited by acupuncture-like stimulation in anesthetized rats
.
Auton Neurosci
.
2008
;
143
(
1–2
):
12
9
.
14.
Hashmi
MF
,
Modi
P
,
Basit
H
, et al
.
Dyspnea. [Updated 2023 Feb 19]
. In:
StatPearls [Internet]
.
Treasure Island (FL)
:
StatPearls Publishing
;
2023
. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499965
15.
Gao
J
,
Zhang
L
,
Wang
Y
,
Lu
B
,
Cui
H
,
Fu
W
, et al
.
Antiarrhythmic effect of acupuncture pretreatment in rats subjected to simulative global ischemia and reperfusion: involvement of adenylate cyclase, protein kinase A, and L-type Ca2+ channel
.
J Physiol Sci
.
2008
;
58
(
6
):
389
96
.
16.
Dong
B
,
Li
C
,
Zhang
X
,
Wang
S
,
Cheng
Z
,
Rong
P
.
Electroacupuncture of neiguan (PC 6) inhibits enhanced voltage-gated sodium currents in ischemic ventricular myocytes
.
J Tradit Chin Med
.
2014
;
34
(
6
):
710
5
.
17.
Wang
W
,
Li
J
,
Meng
X
,
Chen
Y
.
Effect of electronic stimulation at Neiguan (PC 6) acupoint on gene expression of adenosine triphosphate-sensitive potassium channel and protein kinases in rats with myocardial ischemia
.
J Tradit Chin Med
.
2015
;
35
(
5
):
577
82
.
18.
Ji
C
,
Song
F
,
Huang
G
,
Wang
S
,
Liu
H
,
Liu
S
, et al
.
The protective effects of acupoint gel embedding on rats with myocardial ischemia-reperfusion injury
.
Life Sci
.
2018
;
211
:
51
62
.
19.
Han
YL
,
Chen
S
,
Peng
X
.
Electroacupuncture Pretreatment at Neiguan (PC6) attenuates autophagy in rats with myocardial ischemia reperfusion through the phosphatidylinositol 3-kinase-Akt-mammalian target of rapamycin pathway
.
J Tradit Chin Med
.
2021
;
41
(
3
):
455
62
.
20.
Li
S
,
Wang
S
,
Feng
X
,
Chang
Y
,
Yan
D
.
Biao and ben acupoints regulate mitochondrial function through P2X receptor to improve myocardial ischemia
.
Altern Ther Health Med
.
2023
;
29
(
4
):
43
51
.
21.
Chavan
SS
,
Tracey
KJ
.
Regulating innate immunity with dopamine and electroacupuncture
.
Nat Med
.
2014
;
20
(
3
):
239
41
.
22.
Harris
RE
,
Zubieta
JK
,
Scott
DJ
,
Napadow
V
,
Gracely
RH
,
Clauw
DJ
.
Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs)
.
Neuroimage
.
2009
;
47
(
3
):
1077
85
.
23.
Smith
FW
Jr
.
Acupuncture for cardiovascular disorders
.
Probl Vet Med
.
1992
;
4
(
1
):
125
31
.
24.
Li
CX
,
Li
ZX
,
Wang
D
,
Zhang
RY
,
Wang
YH
,
Zeng
Y
, et al
.
[Advances in the clinical research on acupuncture in treatment of respiratory diseases]
.
Zhen Ci Yan Jiu
.
2020
;
45
(
2
):
169
72
.
25.
Soulié de Mourant
GL
.
Acupuncture chinoise
.
Paris
:
Maloine
;
1972
.
26.
Writing Committee MembersACC/AHA Joint Committee Members
.
2022 AHA/ACC/HFSA guideline for the management of heart failure
.
J Card Fail
.
2022
;
28
(
5
):
e1
67
.
27.
Heidenreich
PA
,
Albert
NM
,
Allen
LA
,
Bluemke
DA
,
Butler
J
,
Fonarow
GC
, et al
.
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association
.
Circ Heart Fail
.
2013
;
6
(
3
):
606
19
.
28.
Khera
R
,
Kondamudi
N
,
Zhong
L
,
Vaduganathan
M
,
Parker
J
,
Das
SR
, et al
.
Temporal trends in heart failure incidence among Medicare beneficiaries across risk factor strata, 2011 to 2016
.
JAMA Netw Open
.
2020
;
3
(
10
):
e2022190
.
29.
Tsao
CW
,
Lyass
A
,
Enserro
D
,
Larson
MG
,
Ho
JE
,
Kizer
JR
, et al
.
Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction
.
JACC Heart Fail
.
2018
;
6
(
8
):
678
85
.
30.
Dunlay
SM
,
Roger
VL
,
Redfield
MM
.
Epidemiology of heart failure with preserved ejection fraction
.
Nat Rev Cardiol
.
2017
;
14
(
10
):
591
602
.
31.
Agarwal
MA
,
Fonarow
GC
,
Ziaeian
B
.
National trends in heart failure hospitalizations and readmissions from 2010 to 2017
.
JAMA Cardiol
.
2021
;
6
(
8
):
952
6
.
32.
Ni
H
,
Xu
J
.
Recent trends in heart failure-related mortality: United States, 2000-2014
.
NCHS Data Brief
;
2015
; p.
18
.
33.
Virani
SS
,
Alonso
A
,
Aparicio
HJ
,
Benjamin
EJ
,
Bittencourt
MS
,
Callaway
CW
, et al
.
Heart disease and stroke statistics–2021 update: a report from the American Heart Association
.
Circulation
.
2021
;
143
(
8
):
e254
743
.
34.
Savitz
ST
,
Leong
T
,
Sung
SH
,
Lee
K
,
Rana
JS
,
Tabada
G
, et al
.
Contemporary reevaluation of race and ethnicity with outcomes in heart failure
.
J Am Heart Assoc
.
2021
;
10
(
3
):
e016601
.
35.
Vivo
RP
,
Krim
SR
,
Liang
L
,
Neely
M
,
Hernandez
AF
,
Eapen
ZJ
, et al
.
Short- and long-term rehospitalization and mortality for heart failure in 4 racial/ethnic populations
.
J Am Heart Assoc
.
2014
;
3
(
5
):
e001134
.
36.
Rathore
SS
,
Foody
JM
,
Wang
Y
,
Smith
GL
,
Herrin
J
,
Masoudi
FA
, et al
.
Race, quality of care, and outcomes of elderly patients hospitalized with heart failure
.
JAMA
.
2003
;
289
(
19
):
2517
24
.
37.
Hajouli
S
,
Ludhwani
D
.
Heart failure and ejection fraction
. [Updated 2022 Dec 23]. In:
StatPearls [Internet]
.
Treasure Island (FL)
:
StatPearls Publishing
;
2023
. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553115/
38.
Schwinger
RHG
.
Pathophysiology of heart failure
.
Cardiovasc Diagn Ther
.
2021
;
11
(
1
):
263
76
.
39.
American Heart Association [Internet]
. Dallas: American Heart Association [Internet]. Dallas: Classes of Heart Failure [cited 2023 April 2]. Available from: https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/classes-of-heart-failure
40.
Tanai
E
,
Frantz
S
.
Pathophysiology of heart failure
.
Compr Physiol
.
2015
;
6
(
1
):
187
214
.
41.
Del Gobbo
LC
,
Kalantarian
S
,
Imamura
F
,
Lemaitre
R
,
Siscovick
DS
,
Psaty
BM
, et al
.
Contribution of major life-style risk factors for incident heart failure in older adults: the Cardiovascular Health Study
.
JACC Heart Fail
.
2015
;
3
(
7
):
520
8
.
42.
Khan
SS
,
Ning
H
,
Shah
SJ
,
Yancy
CW
,
Carnethon
M
,
Berry
JD
, et al
.
10-year risk equations for incident heart failure in the general population
.
J Am Coll Cardiol
.
2019
;
73
(
19
):
2388
97
.
43.
Zelniker
TA
,
Wiviott
SD
,
Raz
I
,
Im
K
,
Goodrich
EL
,
Bonaca
MP
, et al
.
SGLT2 inhibitors for primary and second-ary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
.
Lancet
.
2019
;
393
(
10166
):
31
9
.
44.
Huelsmann
M
,
Neuhold
S
,
Resl
M
,
Strunk
G
,
Brath
H
,
Francesconi
C
, et al
.
PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial
.
J Am Coll Cardiol
.
2013
;
62
(
15
):
1365
72
.
45.
Ammar
KA
,
Jacobsen
SJ
,
Mahoney
DW
,
Kors
JA
,
Redfield
MM
,
Burnett
JC
Jr
, et al
.
Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community
.
Circulation
.
2007
;
115
(
12
):
1563
70
.
46.
Shah
AM
,
Claggett
B
,
Loehr
LR
,
Chang
PP
,
Matsushita
K
,
Kitzman
D
, et al
.
Heart failure stages among older adults in the community: the Atherosclerosis Risk in Communities study
.
Circulation
.
2017
;
135
(
3
):
224
40
.
47.
Jong
P
,
Yusuf
S
,
Rousseau
MF
,
Ahn
SA
,
Bangdiwala
SI
.
Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study
.
Lancet
.
2003
;
361
(
9372
):
1843
8
.
48.
Køber
L
,
Torp-Pedersen
C
,
Carlsen
JE
,
Bagger
H
,
Eliasen
P
,
Lyngborg
K
, et al
.
A clinical trial of the angiotensin-converting–enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
.
N Engl J Med
.
1995
;
333
(
25
):
1670
6
.
49.
Echouffo-Tcheugui
JB
,
Erqou
S
,
Butler
J
,
Yancy
CW
,
Fonarow
GC
.
Assessing the risk of progression from asymptomatic left ventricular dysfunction to overt heart failure: a systematic overview and meta-analysis
.
JACC Heart Fail
.
2016
;
4
:
237
48
.
50.
Beygui
F
,
Cayla
G
,
Roule
V
,
Roubille
F
,
Delarche
N
,
Silvain
J
, et al
.
Early aldosterone blockade in acute myocardial infarction: the ALBATROSS randomized clinical trial
.
J Am Coll Cardiol
.
2016
;
67
(
16
):
1917
27
.
51.
Moser
DK
,
Dickson
V
,
Jaarsma
T
,
Lee
C
,
Stromberg
A
,
Riegel
B
.
Role of self-care in the patient with heart failure
.
Curr Cardiol Rep
.
2012
;
14
(
3
):
265
75
.
52.
Li
ZH
,
Brand
E
,
Wiseman
N
.
Pathomechanisms of the heart
. In:
Paradigm pubns
;
2006
.
53.
Institute of traditional medicine [Internet]
.
Portland
: Heart Fire. [cited 2023 April 2]. Available from: http://www.itmonline.org/5organs/heart.htm.
54.
HuangFu
M
The systematic classic of acupuncture and moxibustion: huang-Ti chen chiu chia I ching (Jia Yi jing) blue poppy Pr
.
First Edition
;
2004
.
55.
Li
H
,
Wu
C
,
Yan
C
,
Zhao
S
,
Yang
S
,
Liu
P
, et al
.
Cardioprotective effect of transcutaneous electrical acupuncture point stimulation on perioperative elderly patients with coronary heart disease: a prospective, randomized, controlled clinical trial
.
Clin Interv Aging
.
2019
;
14
:
1607
14
.
56.
Ho
FM
,
Huang
PJ
,
Lo
HM
,
Lee
FK
,
Chern
TH
,
Chiu
TW
, et al
.
Effect of acupuncture at nei-kuan on left ventricular function in patients with coronary artery disease
.
Am J Chin Med
.
1999
;
27
(
2
):
149
56
.
57.
Wang
JY
,
Zhang
J
,
Liu
Y
,
Gao
YM
,
Sun
JJ
,
Liu
XM
.
Acupuncture combined with western medication in treatment of type 2 diabetes mellitus with angina pectoris of coronary heart disease: a randomized controlled study
.
Zhongguo Zhen Jiu
.
2021
;
41
(
4
):
371
5
.
58.
Li
L
,
Chen
H
,
Xi
Y
,
Wang
X
,
Han
G
,
Zhou
Y
, et al
.
Comparative observation on effect of electric acupuncture of neiguan (P 6) at chen time versus xu time on left ventricular function in patients with coronary heart disease
.
J Tradit Chin Med
.
1994
;
14
(
4
):
262
5
.
59.
Ning
S
,
Zhao
L
,
Xu
L
,
Huang
Y
,
Pang
Y
,
Huang
D
.
Effects of slow twisting needle insertion and tubing needle insertion at Neiguan (PC 6) on cardiovascular function: a comparative study
.
Zhongguo Zhen Jiu
.
2016
;
36
(
1
):
48
52
.
60.
Xiao
QS
,
Zhang
B
,
Ma
MY
,
Deng
MH
,
Yang
YZ
.
Effect of acupuncture on acute left heart failure by PiCCO technique
.
Zhongguo Zhong Xi Yi Jie He Za Zhi
.
2014
;
34
(
2
):
149
52
.Chinese.
61.
Middlekauff
HR
,
Hui
K
,
Yu
JL
,
Hamilton
MA
,
Fonarow
GC
,
Moriguchi
J
, et al
.
Acupuncture inhibits sympathetic activation during mental stress in advanced heart failure patients
.
J Card Fail
.
2002
;
8
(
6
):
399
406
.
62.
Kristen
AV
,
Schuhmacher
B
,
Strych
K
,
Lossnitzer
D
,
Friederich
HC
,
Hilbel
T
, et al
.
Acupuncture improves exercise tolerance of patients with heart failure: a placebo-controlled pilot study
.
Heart
.
2010
;
96
(
17
):
1396
400
.
63.
Ceyhan
Ö
,
Taşcı
S
,
Elmalı
F
,
Doğan
A
.
The effect of acupressure on cardiac rhythm and heart rate among patients with atrial fibrillation: the relationship between heart rate and fatigue
.
Altern Ther Health Med
.
2019
;
25
(
1
):
12
9
.
64.
Zhou
JR
.
Effect of auriculo-acupuncture plus needle embedding in heart point on left cardiac, humoral and endocrine function
.
Zhongguo Zhong Xi Yi Jie He Za Zhi
.
1993
;
13
(
3
):
153
4
, 132.
65.
Suzuki
M
,
Muro
S
,
Ando
Y
,
Omori
T
,
Shiota
T
,
Endo
K
, et al
.
A randomized, placebo-controlled trial of acupuncture in patients with Chronic Obstructive Pulmonary Disease (COPD): the COPD-Acupuncture Trial (CAT)
.
Arch Intern Med
.
2012
;
172
(
11
):
878
86
.
66.
Gao
X
,
Wang
D
,
Wang
X
,
Wang
P
,
Fan
Y
,
Chen
X
, et al
.
Penetration moxibustion with different dosage for insomnia of insufficiency of heart and spleen type
.
Zhongguo Zhen Jiu
.
2016
;
36
(
11
):
1139
43
.
67.
Yuan
SC
,
Huang
XL
,
Hua
SY
,
Zhou
YH
,
Rui
QL
.
Effect of acupuncture on diaphragmatic function in patients with AECOPD type II respiratory failure evaluated by ultrasound detection
.
Zhongguo Zhen Jiu
.
2021
;
41
(
7
):
703
10
.
68.
Deering
BM
,
Fullen
B
,
Egan
C
,
McCormack
N
,
Kelly
E
,
Pender
M
, et al
.
Acupuncture as an adjunct to pulmonary rehabilitation
.
J Cardiopulm Rehabil Prev
.
2011
;
31
(
6
):
392
9
.
69.
Pai
HJ
,
Azevedo
RS
,
Braga
AL
,
Martins
LC
,
Saraiva-Romanholo
BM
,
Martins
MA
, et al
.
A randomized, controlled, crossover study in patients with mild and moderate asthma undergoing treatment with traditional Chinese acupuncture
.
Clinics
.
2015
;
70
(
10
):
663
9
.
70.
Doğan
N
,
Taşcı
S
.
The effects of acupressure on quality of life and dyspnea in lung cancer: a randomized, controlled trial
.
Altern Ther Health Med
.
2020
;
26
(
1
):
49
56
.
71.
Minchom
A
,
Punwani
R
,
Filshie
J
,
Bhosle
J
,
Nimako
K
,
Myerson
J
, et al
.
A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma
.
Eur J Cancer
.
2016
;
61
:
102
10
.
72.
Deng
XY
,
Xu
TS
.
Clinical observation of acupuncture combined with sertraline hydrochloride tablets on tumor-related depression
.
Zhongguo Zhen Jiu
.
2019
;
39
(
4
):
379
83
.
73.
Choi
JY
,
Jung
HJ
,
Kim
JI
,
Lee
MS
,
Kang
KW
,
Roh
YL
, et al
.
A randomized pilot study of acupuncture as an adjunct therapy in adult asthmatic patients
.
J Asthma
.
2010
;
47
(
7
):
774
80
.
74.
Feng
J
,
Wang
X
,
Li
X
,
Zhao
D
,
Xu
J
.
Acupuncture for Chronic Obstructive Pulmonary Disease (COPD): a multicenter, randomized, sham-controlled trial
.
Medicine
.
2016
;
95
(
40
):
e4879
.
75.
Levy
I
,
Elimeleh
Y
,
Gavrieli
S
,
Attias
S
,
Schiff
A
,
Oliven
A
, et al
.
Treatment of acute exacerbations of chronic obstructive pulmonary disease with acupuncture during hospitalization: a three-arm double-blinded randomized sham-controlled trial
.
Acupunct Med
.
2022
;
40
(
6
):
505
15
.
76.
Maa
SH
,
Sun
MF
,
Hsu
KH
,
Hung
TJ
,
Chen
HC
,
Yu
CT
, et al
.
Effect of acupuncture or acupressure on quality of life of patients with chronic obstructive asthma: a pilot study
.
J Altern Complement Med
.
2003
;
9
(
5
):
659
70
.
77.
Whale
CA
,
MacLaran
SJ
,
Whale
CI
,
Barnett
M
.
Pilot study to assess the credibility of acupuncture in acute exacerbations of chronic obstructive pulmonary disease
.
Acupunct Med
.
2009
;
27
(
1
):
13
5
.
78.
Ali
ZA
,
Eladl
HM
,
Abdelbasset
WK
,
Eid
MM
,
Mosa
HE
,
Elsayeh
SM
.
Inhalation injury in adult males: evaluation of the short-term efficacy of transcutaneous electrical acupoint stimulation on pulmonary functions and diaphragmatic mobility after burn: a double-blind randomized controlled study
.
Burns
.
2022
;
48
(
8
):
1933
9
.
79.
Jones
AY
,
Ngai
SP
,
Hui-Chan
CW
,
Yu
HP
.
Acute effects of acu-TENS on FEV1 and blood Β endorphin level in chronic obstructive pulmonary disease
.
Altern Ther Health Med
.
2011
;
17
(
5
):
8
13
.
80.
Lewith
GT
,
Prescott
P
,
Davis
CL
.
Can a standardized acupuncture technique palliate disabling breathlessness: a single-blind, placebo-controlled crossover study
.
Chest
.
2004
;
125
(
5
):
1783
90
.
81.
Lau
KS
,
Jones
AY
.
A single session of Acu-TENS increases FEV1 and reduces dyspnoea in patients with chronic obstructive pulmonary disease: a randomised, placebo-controlled trial
.
Aust J Physiother
.
2008
;
54
(
3
):
179
84
.
82.
Suzuki
M
,
Namura
K
,
Ohno
Y
,
Tanaka
H
,
Egawa
M
,
Yokoyama
Y
, et al
.
The effect of acupuncture in the treatment of chronic obstructive pulmonary disease
.
J Altern Complement Med
.
2008
;
14
(
9
):
1097
105
.
83.
Liu
X
,
Fan
T
,
Lan
Y
,
Dong
S
,
Fu
J
,
Mao
B
.
Effects of transcutaneous electrical acupoint stimulation on patients with stable chronic obstructive pulmonary disease: a prospective, single-blind, randomized, placebo-controlled study
.
J Altern Complement Med
.
2015
;
21
(
10
):
610
6
.
You do not currently have access to this content.